🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

HF patients with Cordella PA pressure monitor had reduction in HF Hospitalization/Mortality (all cause) when compared to historical and contemporary controls. Event rates in contemporary control and Cordella arms were lower than in historical groups. shorturl.at/CzoE8

In #DCD #HeartTransplantation, #NRP was associated with better survival when compared with direct procurement and perfusion. shorturl.at/67Hlv

JHLT From 20 yrs of experience Mayo Clinic Transplant🫀 Younger age & earlier conversion post #HT ➡️increased risk of early rejection on #sirolimus Rejection on SRL 🚫associated with ⬆️CAV Findings may aid in improving protocols to maximize benefits of #CNI-free immunosuppression

New in JACC HF: Results of the ALIVE Trial using the Revivient TC system for #LV dimension reduction. shorturl.at/sjwgL

New in JACC HF: Impact of Preeclamsia on Cardiac Allograft Survival: * Similar cardiac graft survival at 2-year post delivery. * Babies of mothers with preeclamsia had lower weight and gestational age and higher complications. shorturl.at/12QKd

#AFib symptom questionnaire in #HF pts ⭐️Measures sx burden related to AF ⭐️⬆️Endpoint efficiency vs time to first event ⭐️AF sx burden correlated to device burden ‼️Patient centered care by integrating sx burden & disease trajectory to guide tx doi.org/10.1016/j.jchf…

New in JACC HF: Would you discontinue GDMT in patients with #HFimpEF? If so, how would you select the ones with lowest risk of deterioration? shorturl.at/rGHe7

Congratulations to Drs. Sara Inglis, Kennedy, and da Silva for their (giant PA aneurysm) case presentation at The ISHLT

Nice to see the research of our Mayo #HeartTx team on transition from Tacrolimus to Sirolimus already serving as landmark for the field Sara Inglis Andrew (Drew) Rosenbaum, M.D. (Drew Rosenbaum)

Dr. Goswami from Mayo Clinic CV FL sharing their experience on the use of #Impella 5.5 and BiV MCS for bridging to #HeartTx

Vena contracta seems to be the most important echo parameter for evaluation of AI in #LVADs. #LHC May aid hemodynamic optimization

The amazing #ISHLT2025 Roving Reporters have been sharing their insights and takeaways all week. 💡📲 Make sure you're following along: 🔗 bit.ly/4iCx7W0 #MCS #PVD #AHFTX #ALFTX

At many transplant centers in the U.S., people who have a high body mass index (BMI) don't qualify for #kidneytransplant. But at Mayo Clinic patients may have options. #obesity Ty Diwan Aleksandra Kukla mayocl.in/3ENNsJB

Mayo Clinic #HeartTx team certainly enjoyed The ISHLT 2025. Coming back with new ideas to innovate patient care

#EXTRAVIRGINOLIVEOIL #EVOO

Congrats to our #LVAD team for its 500th #LVAD implant. Striving and innovating to save and improve quality of life

#JACC HF: From the CABANA trial: Patients with #HFpEF benefited > from #Afib ablation: ⬇️Death/CV hospitalization ⬇️AF recurrence Despite greater benefit of HFpEF patients, their risk of recurrence remained higher than in those without HFpEF shorturl.at/3F9aa

Amazing case presentation by Sara Inglis at the #HeartFailure2025 clinical case awards Unique diagnosis of severe #AR using #ICE & invasive #hemodynamics in a patient with #LVAD #HM3 support Adrian da Silva Anju Bhardwaj MD FACC BiykemBozkurt Mayo Clinic Rochester Cardiology Fellows Johann Bauersachs Jozine ter Maaten

Abhishek, Medical Director of the Mayo Clinic Heart Rhythm & Physiological Monitoring Laboratory, joins the latest session of #ECG Insights for #CardiacSonographers & #CardiacTechnicians. Watch session 2 now: cveducation.mayo.edu/lp/videos?vid=…

New in JACC HF: Eplerenone decreased diffuse myocardial fibrosis in non-obstructive HCM.